• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码 RNA 网络及其在乳腺癌中的分子靶标。

The network of non-coding RNAs and their molecular targets in breast cancer.

机构信息

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.

LTTA, University of Ferrara, Ferrara, Italy.

出版信息

Mol Cancer. 2020 Mar 18;19(1):61. doi: 10.1186/s12943-020-01181-x.

DOI:10.1186/s12943-020-01181-x
PMID:32188472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7079433/
Abstract

BACKGROUND

Non-coding RNAs are now recognized as fundamental components of the cellular processes. Non-coding RNAs are composed of different classes, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Their detailed roles in breast cancer are still under scrutiny.

MAIN BODY

We systematically reviewed from recent literature the many functional and physical interactions of non-coding RNAs in breast cancer. We used a data driven approach to establish the network of direct, and indirect, interactions. Human curation was essential to de-convolute and critically assess the experimental approaches in the reviewed articles. To enrol the scientific papers in our article cohort, due to the short time span (shorter than 5 years) we considered the journal impact factor rather than the citation number. The outcome of our work is the formal establishment of different sub-networks composed by non-coding RNAs and coding genes with validated relations in human breast cancer. This review describes in a concise and unbiased fashion the core of our current knowledge on the role of lncRNAs, miRNAs and other non-coding RNAs in breast cancer.

CONCLUSIONS

A number of coding/non-coding gene interactions have been investigated in breast cancer during recent years and their full extent is still being established. Here, we have unveiled some of the most important networks embracing those interactions, and described their involvement in cancer development and in its malignant progression.

摘要

背景

非编码 RNA 现在被认为是细胞过程的基本组成部分。非编码 RNA 由不同的类别组成,包括 microRNAs (miRNAs) 和长非编码 RNA (lncRNAs)。它们在乳腺癌中的详细作用仍在研究中。

主要内容

我们从最近的文献中系统地综述了非编码 RNA 在乳腺癌中的许多功能和物理相互作用。我们使用数据驱动的方法来建立直接和间接相互作用的网络。对综述文章中的实验方法进行去卷积和严格评估,人类策展至关重要。为了将科学论文纳入我们的文章队列,由于时间跨度较短(短于 5 年),我们考虑了期刊影响因子而不是引用数量。我们工作的结果是正式建立了不同的子网络,这些子网络由非编码 RNA 和编码基因组成,在人类乳腺癌中有经过验证的关系。本综述以简洁、无偏见的方式描述了我们目前对 lncRNA、miRNA 和其他非编码 RNA 在乳腺癌中作用的核心认识。

结论

近年来,已经研究了许多编码/非编码基因相互作用在乳腺癌中的作用,其全部范围仍在建立之中。在这里,我们揭示了一些最重要的网络,包括这些相互作用,并描述了它们在癌症发展及其恶性进展中的参与。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/33ac4f89ed55/12943_2020_1181_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/61bcb8b90b5d/12943_2020_1181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/ad0b114e7b25/12943_2020_1181_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/c0c79856910a/12943_2020_1181_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/ae27fb39b9dc/12943_2020_1181_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/f71a254e4354/12943_2020_1181_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/33ac4f89ed55/12943_2020_1181_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/61bcb8b90b5d/12943_2020_1181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/ad0b114e7b25/12943_2020_1181_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/c0c79856910a/12943_2020_1181_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/ae27fb39b9dc/12943_2020_1181_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/f71a254e4354/12943_2020_1181_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f4/7079433/33ac4f89ed55/12943_2020_1181_Fig6_HTML.jpg

相似文献

1
The network of non-coding RNAs and their molecular targets in breast cancer.非编码 RNA 网络及其在乳腺癌中的分子靶标。
Mol Cancer. 2020 Mar 18;19(1):61. doi: 10.1186/s12943-020-01181-x.
2
Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer.miRNAs 和长非编码 RNA 对人乳腺癌血管生成的调控。
Pathol Res Pract. 2021 Mar;219:153326. doi: 10.1016/j.prp.2020.153326. Epub 2021 Jan 13.
3
Targetable long non-coding RNAs in cancer treatments.癌症治疗中的靶向长非编码 RNA。
Cancer Lett. 2018 Apr 1;418:119-124. doi: 10.1016/j.canlet.2018.01.042. Epub 2018 Jan 16.
4
Current Status of Long Non-Coding RNAs in Human Breast Cancer.长链非编码RNA在人类乳腺癌中的研究现状
Int J Mol Sci. 2016 Sep 6;17(9):1485. doi: 10.3390/ijms17091485.
5
New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.长非编码 RNA 在乳腺癌中的新见解:生物学功能与治疗前景。
Exp Mol Pathol. 2021 Jun;120:104640. doi: 10.1016/j.yexmp.2021.104640. Epub 2021 Apr 17.
6
Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.长非编码 RNA 作为乳腺癌的监测工具和治疗靶点。
Cell Oncol (Dordr). 2019 Feb;42(1):1-12. doi: 10.1007/s13402-018-0412-6. Epub 2018 Oct 25.
7
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.长非编码 RNA:在人类非三阴性和三阴性乳腺癌的靶向诊断、预后和改进治疗策略中的意义。
Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018.
8
Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer.长链非编码 RNA 作为乳腺癌系统治疗耐药性的新主控调节剂。
Int J Mol Sci. 2018 Sep 11;19(9):2711. doi: 10.3390/ijms19092711.
9
Long Non-Coding RNA and Breast Cancer.长链非编码 RNA 与乳腺癌。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819843889. doi: 10.1177/1533033819843889.
10
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.miRNA 和长非编码 RNA:在乳腺癌和卵巢癌中的分子功能和临床价值。
Expert Rev Mol Diagn. 2018 Nov;18(11):963-979. doi: 10.1080/14737159.2018.1538794. Epub 2018 Oct 29.

引用本文的文献

1
LncRNA SNHG15 acts as a ceRNA to promote breast cancer progression through the miR-153-3p/KLF5 signal axis.长链非编码RNA SNHG15作为竞争性内源RNA,通过miR-153-3p/KLF5信号轴促进乳腺癌进展。
J Cancer. 2025 Jul 28;16(12):3589-3598. doi: 10.7150/jca.116946. eCollection 2025.
2
The role of RANBP1 in regulating MiRNA expression and apoptosis in breast cancer cells.RANBP1在调节乳腺癌细胞中微小RNA表达及细胞凋亡方面的作用。
Genes Genomics. 2025 Aug 21. doi: 10.1007/s13258-025-01664-5.
3
Role and therapeutic potential of the NEDD4 family in breast cancer.

本文引用的文献

1
LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling.长链非编码 RNA CCAT1 通过激活 WNT/β-连环蛋白信号通路促进乳腺癌干细胞功能。
Theranostics. 2019 Oct 1;9(24):7384-7402. doi: 10.7150/thno.37892. eCollection 2019.
2
LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.LINC00673 被 YY1 激活,并通过 miR-515-5p/MARK4/Hippo 信号通路促进乳腺癌细胞的增殖。
J Exp Clin Cancer Res. 2019 Oct 17;38(1):418. doi: 10.1186/s13046-019-1421-7.
3
Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells.
NEDD4家族在乳腺癌中的作用及治疗潜力
Front Pharmacol. 2025 Jun 4;16:1587675. doi: 10.3389/fphar.2025.1587675. eCollection 2025.
4
Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy.HIV抑制剂达匹韦林对三阴性乳腺癌细胞的多方面影响揭示了作为新疗法靶点的潜在实体。
Sci Rep. 2024 Dec 3;14(1):30103. doi: 10.1038/s41598-024-79789-y.
5
Identification of modules and key genes associated with breast cancer subtypes through network analysis.通过网络分析鉴定与乳腺癌亚型相关的模块和关键基因。
Sci Rep. 2024 May 29;14(1):12350. doi: 10.1038/s41598-024-61908-4.
6
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study.长链非编码RNA RP11-10E18.7与长链非编码RNA RP11-481C4.2协同作用影响乳腺癌患者的总生存期:一项基于TCGA的回顾性研究。
Transl Cancer Res. 2023 Nov 30;12(11):3156-3165. doi: 10.21037/tcr-23-1941. Epub 2023 Nov 17.
7
The p53/ZEB1-PLD3 feedback loop regulates cell proliferation in breast cancer.p53/ZEB1-PLD3 反馈环调节乳腺癌细胞增殖。
Cell Death Dis. 2023 Nov 17;14(11):751. doi: 10.1038/s41419-023-06271-4.
8
MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis.微小 RNA 介导的肿瘤微环境细胞与乳腺癌细胞在骨转移过程中的相互作用。
Breast Cancer. 2023 Nov;30(6):910-925. doi: 10.1007/s12282-023-01491-0. Epub 2023 Aug 14.
9
Physiological and pathological consequences of exosomes at the blood-brain-barrier interface.血脑屏障界面外泌体的生理和病理后果。
Cell Commun Signal. 2023 May 19;21(1):118. doi: 10.1186/s12964-023-01142-z.
10
MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer.MIR497HG 衍生的 miR-195 和 miR-497 通过 PI3K/AKT 信号通路介导乳腺癌对他莫昔芬的耐药性。
Adv Sci (Weinh). 2023 Apr;10(12):e2204819. doi: 10.1002/advs.202204819. Epub 2023 Feb 23.
长链非编码 RNA LINC02582 通过 miR-200c 的下游作用和 CHK1 促进乳腺癌细胞的放射抵抗。
Cell Death Dis. 2019 Oct 10;10(10):764. doi: 10.1038/s41419-019-1996-0.
4
Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.长链非编码 RNA NONHSAT101069 通过 NONHSAT101069/miR-129-5p/Twist1 轴促进乳腺癌细胞对表阿霉素的耐药性、迁移和侵袭。
Oncogene. 2019 Nov;38(47):7216-7233. doi: 10.1038/s41388-019-0904-5. Epub 2019 Aug 23.
5
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis.Eleanor ncRNAs 通过激活 ESR1 基因座的拓扑结构域来平衡细胞凋亡。
Nat Commun. 2019 Aug 22;10(1):3778. doi: 10.1038/s41467-019-11378-4.
6
The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.长链非编码RNA MIR210HG通过作为miR-1226-3p的竞争性内源RNA来调控浸润性乳腺癌中黏蛋白-1c的表达,从而促进肿瘤转移。
Aging (Albany NY). 2019 Aug 10;11(15):5646-5665. doi: 10.18632/aging.102149.
7
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.lncRNAs 的转录图谱揭示了 LINC00511 在 ER 阴性乳腺癌中的致癌功能。
Cell Death Dis. 2019 Aug 8;10(8):599. doi: 10.1038/s41419-019-1835-3.
8
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.长链非编码 RNA H19 通过自噬促进乳腺癌对他莫昔芬的耐药性。
J Hematol Oncol. 2019 Jul 24;12(1):81. doi: 10.1186/s13045-019-0747-0.
9
CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.CCAT1通过抑制miR-218/ZFX信号通路促进三阴性乳腺癌进展。
Aging (Albany NY). 2019 Jul 16;11(14):4858-4875. doi: 10.18632/aging.102080.
10
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.长非编码 RNA LUCAT1/miR-5582-3p/TCF7L2 轴通过 Wnt/β-catenin 通路调节乳腺癌干细胞特性。
J Exp Clin Cancer Res. 2019 Jul 12;38(1):305. doi: 10.1186/s13046-019-1315-8.